Insider Trading History of Kutzkey Tim


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kutzkey Tim since year 2005. The trader's CIK number is 1614186. At the time of the last reporting, Kutzkey Tim was the Other of Ngm Biopharmaceuticals Inc . (stock ticker symbol NGM). See this page for all insider trading activities at Ngm Biopharmaceuticals Inc .

Note that in the past Kutzkey Tim also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Kutzkey Tim since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-06-19 NGM Ngm Biopharmaceuticals Inc Buy 15,214 13.91 211,672
2019-06-20 NGM Ngm Biopharmaceuticals Inc Buy 15,400 13.86 213,382
2019-06-21 NGM Ngm Biopharmaceuticals Inc Buy 3,763 14.03 52,791
2019-06-12 NGM Ngm Biopharmaceuticals Inc Buy 7,500 14.00 104,992
2019-06-13 NGM Ngm Biopharmaceuticals Inc Buy 11,500 14.13 162,506
2019-06-14 NGM Ngm Biopharmaceuticals Inc Buy 10,760 14.00 150,683
2019-06-07 NGM Ngm Biopharmaceuticals Inc Buy 12,600 13.66 172,179
2019-06-11 NGM Ngm Biopharmaceuticals Inc Buy 10,900 13.83 150,714
2019-06-04 NGM Ngm Biopharmaceuticals Inc Buy 12,600 13.39 168,764
2019-06-06 NGM Ngm Biopharmaceuticals Inc Buy 12,600 13.40 168,890
2019-05-20 NGM Ngm Biopharmaceuticals Inc Buy 50,000 13.50 675,000
2019-05-10 NGM Ngm Biopharmaceuticals Inc Buy 17,923 13.85 248,233
2019-05-07 NGM Ngm Biopharmaceuticals Inc Buy 57,000 14.10 803,700
2019-04-08 NGM Ngm Biopharmaceuticals Inc Buy 1,890,000 16.00 30,240,000
2017-10-27 IMDZ Immune Design Corp. Buy 2,681,000 4.10 10,992,099

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kutzkey Tim (Other of Ngm Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.